These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28698094)

  • 21. Vitiligo: Mechanistic insights lead to novel treatments.
    Frisoli ML; Harris JE
    J Allergy Clin Immunol; 2017 Sep; 140(3):654-662. PubMed ID: 28778794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo.
    Tembhre MK; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
    Clin Chim Acta; 2013 Sep; 424():27-32. PubMed ID: 23680073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo.
    Yang L; Wei Y; Sun Y; Shi W; Yang J; Zhu L; Li M
    Acta Derm Venereol; 2015 Jul; 95(6):664-70. PubMed ID: 25721262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells.
    Lin M; Zhang BX; Shen N; Dong XJ; Zhang C; Qi XY; Zhu J; Li YZ; Man MQ; Tu CX
    Eur J Dermatol; 2014; 24(6):676-82. PubMed ID: 25335433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker.
    Pandya JM; Lundell AC; Andersson K; Nordström I; Theander E; Rudin A
    Arthritis Res Ther; 2017 Feb; 19(1):20. PubMed ID: 28148302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of ischemia-modified albumin in predicting oxidative stress in patients with vitiligo.
    Ataş H; Kocabıyık M; Gönül M; Öztürk Y; Kavutçu M
    Biomark Med; 2017 May; 11(6):439-449. PubMed ID: 28598198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the treatment options for vitiligo: activated low-dose cytokines-based therapy.
    Lotti T; Hercogova J; Fabrizi G
    Expert Opin Pharmacother; 2015; 16(16):2485-96. PubMed ID: 26372794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study on some oxidative stress parameters in blood of vitiligo patients before and after combined therapy.
    Zheleva A; Nikolova G; Karamalakova Y; Hristakieva E; Lavcheva R; Gadjeva V
    Regul Toxicol Pharmacol; 2018 Apr; 94():234-239. PubMed ID: 29454011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo.
    Steitz J; Wenzel J; Gaffal E; Tüting T
    Eur J Cell Biol; 2004 Dec; 83(11-12):797-803. PubMed ID: 15679123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin.
    Barygina V; Becatti M; Lotti T; Moretti S; Taddei N; Fiorillo C
    J Dermatol Sci; 2015 Aug; 79(2):163-70. PubMed ID: 26051876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in understanding vitiligo.
    Manga P; Elbuluk N; Orlow SJ
    F1000Res; 2016; 5():. PubMed ID: 27635239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo.
    Abdallah M; Abdel-Naser MB; Moussa MH; Assaf C; Orfanos CE
    Eur J Dermatol; 2003; 13(6):548-52. PubMed ID: 14721774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative Stress-Induced Chemokine Production Mediates CD8(+) T Cell Skin Trafficking in Vitiligo.
    Li S; Zhu G; Yang Y; Guo S; Dai W; Wang G; Gao T; Li C
    J Investig Dermatol Symp Proc; 2015 Jul; 17(1):32-3. PubMed ID: 26067315
    [No Abstract]   [Full Text] [Related]  

  • 34. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin.
    Prignano F; Pescitelli L; Becatti M; Di Gennaro P; Fiorillo C; Taddei N; Lotti T
    J Dermatol Sci; 2009 Jun; 54(3):157-67. PubMed ID: 19282153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammasome activation and vitiligo/nonsegmental vitiligo progression.
    Marie J; Kovacs D; Pain C; Jouary T; Cota C; Vergier B; Picardo M; Taieb A; Ezzedine K; Cario-André M
    Br J Dermatol; 2014 Apr; 170(4):816-23. PubMed ID: 24734946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo.
    Khan R; Satyam A; Gupta S; Sharma VK; Sharma A
    Arch Dermatol Res; 2009 Oct; 301(10):731-7. PubMed ID: 19488773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.
    Tembhre MK; Parihar AS; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
    Br J Dermatol; 2015 Apr; 172(4):940-50. PubMed ID: 25376752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100B: Correlation with Active Vitiligo Depigmentation.
    Birlea SA
    J Invest Dermatol; 2017 Jul; 137(7):1408-1410. PubMed ID: 28647026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development.
    Zhou L; Shi YL; Li K; Hamzavi I; Gao TW; Huggins RH; Lim HW; Mi QS
    Pigment Cell Melanoma Res; 2015 May; 28(3):324-9. PubMed ID: 25604047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of circulating CD8+T cells expressing skin homing and cytotoxic molecules in active non-segmental vitiligo.
    Zhang BX; Lin M; Qi XY; Zhang RX; Wei ZD; Zhu J; Man MQ; Tu CX
    Eur J Dermatol; 2013; 23(3):331-8. PubMed ID: 23782916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.